Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Completion Rate
    0%(0/1)
    Active Trials
    1(50%)
    Terminated
    1(50%)

    Phase Distribution

    Not Applicable
    1
    50%
    Early Phase 1
    1
    50%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Early Phase 1First-in-human
    1(50.0%)
    N/ANon-phased studies
    1(50.0%)

    Highest Phase Reached

    Early Phase 1

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Terminated(1)

    Detailed Status

    Terminated1
    Enrolling by invitation1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    0.0%
    Most Advanced
    Early Phase 1

    Trials by Phase

    Early Phase 11 (50.0%)
    N/A1 (50.0%)

    Trials by Status

    terminated150%
    enrolling_by_invitation150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    enrolling_by_invitationnot_applicable

    Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer

    NCT05706025
    terminatedearly_phase_1

    Gastrointestinal STRING Test With Oral Immunotherapy

    NCT04943744

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05706025Not Applicable

    Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer

    Enrolling By Invitation
    NCT04943744Early Phase 1

    Gastrointestinal STRING Test With Oral Immunotherapy

    Terminated

    All 2 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    2